Showing 541 - 560 results of 1,516 for search '"breast cancer"', query time: 0.08s Refine Results
  1. 541

    Biological embodiment of educational attainment and future risk of breast cancer: findings from a French prospective cohort by Cyrille Delpierre, Raphaële Castagné, Eloïse Berger, Gianluca Severi, Marie-Christine Boutron-Ruault, Laura Baglietto, Laure Dossus, Amandine Gelot, Richard Dudouet

    Published 2025-02-01
    “…Background Women with higher educational attainment have a higher risk of developing breast cancer (BC). Despite the acknowledged impact of reproductive and lifestyle factors, some excess risks remain unexplained. …”
    Get full text
    Article
  2. 542
  3. 543

    Copy number amplification of FLAD1 promotes the progression of triple-negative breast cancer through lipid metabolism by Xiao-Qing Song, Tian-Jian Yu, Yang Ou-Yang, Jia-Han Ding, Yi-Zhou Jiang, Zhi-Ming Shao, Yi Xiao

    Published 2025-02-01
    “…Abstract Triple-negative breast cancer (TNBC) is known for frequent copy number alterations (CNAs) and metabolic reprogramming. …”
    Get full text
    Article
  4. 544
  5. 545
  6. 546
  7. 547

    DNA Ligase IV Prevents Replication Fork Stalling and Promotes Cellular Proliferation in Triple Negative Breast Cancer by Rashmi R. Joshi, Sk Imran Ali, Amanda K. Ashley

    Published 2019-01-01
    “…Our investigations focused on triple negative breast cancer cells, as, compared to nonbasal breast cancer, LIG4 is frequently amplified, and an increased gene dose is associated with higher Lig4 expression. …”
    Get full text
    Article
  8. 548
  9. 549

    Analysis of cervical and breast cancer screening behavior and its influencing factors among urban and rural women in Beijing. by Yanqing Gao, Guoxin Liang, Chun Chang, Feng Pan, Fumin Huang, Litong Gong, Liyu Huang

    Published 2025-01-01
    “…<h4>Methods</h4>This study used a multi-stage stratified random sampling method to select 4, 000 women in urban and rural areas of Beijing to analyze their behavior, basic situation, and influencing factors regarding cervical and breast cancer screening.<h4>Results</h4>The sample size of the final included valid analysis was 3861 people, and the screening rate was 27.25% for cervical cancer, 20.64% for breast cancer, 30.46% for at least one screening and 17.43% for both cervical cancer and breast cancer screening. …”
    Get full text
    Article
  10. 550
  11. 551
  12. 552

    Association between Neurofibromatosis Type 1 and Breast Cancer: A Report of Two Cases with a Review of the Literature by Yoon Nae Seo, Young Mi Park

    Published 2015-01-01
    “…Neurofibromatosis type 1 (NF1) is one of the most common genetic diseases in humans and is associated with various benign and malignant tumors, including breast cancer. However, an increased risk of breast cancer in NF1 patients has not been widely recognized or accepted. …”
    Get full text
    Article
  13. 553
  14. 554
  15. 555
  16. 556

    Injectable supramolecular hydrogel co-loading abemaciclib/NLG919 for neoadjuvant immunotherapy of triple-negative breast cancer by Binyu Zhu, Ying Cai, Lingli Zhou, Lei Zhao, Jiameng Chen, Xiaoting Shan, Xujie Sun, Qian You, Xiang Gong, Wen Zhang, Helen He Zhu, Pengcheng Zhang, Yaping Li

    Published 2025-01-01
    “…Abstract The efficacy of cancer immunotherapy relies on a sufficient amount of functional immune cells. Triple-negative breast cancer lacks enough immune cell infiltration, and adjuvant therapy is necessary to prime anti-tumor immunity. …”
    Get full text
    Article
  17. 557
  18. 558
  19. 559

    Dataset of transcriptomic changes induced by naringenin treatment in MCF-7 breast cancer cellsGene Expression Omnibus by Van T. Hoang, Mackenzie L. Hawes, Jack R. Elliott, Steven Elliott, Binghao Zou, Stephen M. Boué, Brian G. Rowan, Bridgette M. Collins-Burow, Jorge A. Belgodere, Muralidharan Anbalagan, Elizabeth C. Martin, Matthew E. Burow

    Published 2025-04-01
    “…To investigate the effects of Nar in breast cancer, based on its activity as a phytoestrogen, we treated MCF-7 ER-positive (ER+) breast cancer cells with Nar (10 µM) and examined transcriptomic changes in MCF-7 cells induced by Nar treatment. …”
    Get full text
    Article
  20. 560